Biotech firm Tobira tables $74M IPO
August 07, 2014 at 15:39 PM EDT
Biopharmaceutical company Tobira Therapeutics has pushed back its IPO due to market conditions, according to IPO research firm Renaissance Capital...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.